Related Experiment Videos

[Painless myocardial ischemia in patients with post-infarction cardiosclerosis]

Kardiologiia
|January 1, 1992
PubMed

Insights

Silent myocardial ischemia (SMI) is common in postinfarction cardiosclerosis, often linked to angina and heart failure. Longer SMI duration correlates with increased risk and specific cardiac conditions.

Area of Science:

  • Cardiology
  • Internal Medicine

Context:

  • Postinfarction cardiosclerosis presents diagnostic challenges.
  • Silent myocardial ischemia (SMI) is a significant concern in these patients.
  • Multimodality assessment is crucial for understanding cardiac events.

Purpose:

  • To investigate the prevalence and characteristics of silent myocardial ischemia (SMI) in patients with postinfarction cardiosclerosis.
  • To explore correlations between SMI duration and clinical factors, echocardiographic findings, and scintigraphic data.

Summary:

  • Holter monitoring, echocardiography, and 201Tl myocardial scintigraphy were used in 40 patients.
  • SMI was detected in 77.5% of patients, with 27 experiencing concurrent angina.
  • SMI duration showed a direct correlation with silent myocardial infarction (r = 0.539; p < 0.05) and was longer in patients with left ventricular failure or myocardial hypertrophy.

Impact:

  • Highlights the high prevalence of SMI in postinfarction cardiosclerosis.
  • Establishes a link between SMI duration and adverse cardiac conditions like angina and heart failure.
  • Suggests that prolonged SMI may indicate a poorer prognosis in this patient group.

Related Concept Videos